CSIMarket
 


Cytrx Corp  (CYTR)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cytrx's Leverage Ratio

CYTR's quarterly Leverage Ratio and Total Liabilities, Equity growth




CYTR Leverage Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Equity Change -24.69 % -28.25 % -9.91 % 12.22 % 4.08 %
Y / Y Total Liabilities Change -69.93 % -90.02 % -89.21 % -91.51 % -63.29 %
Leverage Ratio MRQ 0.19 0.1 0.12 0.13 0.47
Overall Ranking # 307 # 185 # 223 # 290 # 1145
Seq. Equity Change -6.94 % -5.54 % -5.97 % -8.89 % -11.34 %
Seq. Total Liabilities Change 68.79 % -21.38 % -7.95 % -75.39 % -43.99 %



Leverage Ratio third quarter 2019 Comment
Due to net new borrowings of 68.79%, Leverage Ratio detoriated to 0.19, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2019, 30 other companies have achieved lower Leverage Ratio than Cytrx. While Leverage Ratio total ranking has deteriorated compare to previous quarter from 185 to 307.

Explain Leverage Ratio?
Who are CYTR Customers?
Leverage Ratio third quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 31
Healthcare Sector # 121
Overall Market # 307


Leverage Ratio Statistics
High Average Low
15.55 1.48 0.1
(Jun 30 2012)   (Jun 30 2019)




Financial Statements
Cytrx's Equity $ 17 Millions Visit CYTR's Balance sheet
Cytrx's Total Liabilities $ 3 Millions Visit CYTR's Balance sheet
Source of CYTR's Sales Visit CYTR's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2019, within Biotechnology & Drugs Industry Leverage RatioSep 30 2019 MRQ Total LiabilitiesSep 30 2019 MRQ Equity
Eloxx Pharmaceuticals, Inc.  0.50 $ 22.829  Millions$ 45.228  Millions
Trovagene, Inc.  0.50 $ 3.339  Millions$ 6.656  Millions
Halozyme Therapeutics, Inc.  0.50 $ 121.492  Millions$ 245.353  Millions
Scpharmaceuticals Inc.  0.47 $ 27.335  Millions$ 57.886  Millions
Heska Corp  0.46 $ 70.328  Millions$ 153.683  Millions
Pluristem Therapeutics Inc  0.45 $ 7.821  Millions$ 17.527  Millions
Momenta Pharmaceuticals, inc.  0.44 $ 121.844  Millions$ 275.924  Millions
Assembly Biosciences, inc.  0.43 $ 66.856  Millions$ 156.489  Millions
Relmada Therapeutics, Inc.  0.42 $ 2.537  Millions$ 5.977  Millions
Cohbar, Inc.  0.40 $ 4.441  Millions$ 10.978  Millions
Vermillion, Inc.  0.40 $ 4.706  Millions$ 11.827  Millions
Cv Sciences, Inc.  0.39 $ 12.839  Millions$ 33.243  Millions
Akers Biosciences, Inc.  0.38 $ 1.373  Millions$ 3.598  Millions
Evelo Biosciences, Inc.  0.38 $ 30.594  Millions$ 80.546  Millions
Denali Therapeutics Inc.  0.38 $ 164.781  Millions$ 438.197  Millions
Oncternal Therapeutics, Inc.  0.37 $ 6.803  Millions$ 18.150  Millions
Pdl Biopharma, Inc.  0.36 $ 227.727  Millions$ 637.434  Millions
Volitionrx Ltd  0.34 $ 5.975  Millions$ 17.802  Millions
Gritstone Oncology, Inc.  0.33 $ 52.256  Millions$ 156.395  Millions
Proteostasis Therapeutics, Inc.  0.32 $ 22.788  Millions$ 70.121  Millions
Nymox Pharmaceutical Corporation  0.32 $ 1.812  Millions$ 5.650  Millions
Strongbridge Biopharma Plc  0.31 $ 24.671  Millions$ 79.641  Millions
Opiant Pharmaceuticals, Inc.  0.31 $ 9.762  Millions$ 31.606  Millions
Celldex Therapeutics, Inc.  0.30 $ 30.461  Millions$ 101.380  Millions
Pds Biotechnology Corp  0.30 $ 4.659  Millions$ 15.583  Millions
Zymeworks Inc.  0.29 $ 90.512  Millions$ 309.525  Millions
Repligen Corp  0.29 $ 304.490  Millions$ 1,045.118  Millions
Bluebird Bio, Inc.  0.29 $ 420.508  Millions$ 1,471.710  Millions
Neuralstem, Inc.  0.27 $ 1.901  Millions$ 7.043  Millions
Fate Therapeutics Inc  0.27 $ 72.165  Millions$ 268.042  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BDCO's Profile

Stock Price

BDCO's Financials

Business Description

Fundamentals

Charts & Quotes

BDCO's News

Suppliers

BDCO's Competitors

Customers & Markets

Economic Indicators

BDCO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071